EUVIMEDEUVIMED entdecken
Crossref

Clinical Safety and Procedural Performance of the Optima SC Semi-compliant Percutaneous Transluminal Coronary Angioplasty Balloon Catheter in Coronary Intervention: A Multicenter Post-Market Study

Chirag Jagdish Parikh, Anuj Sarda, Anup Ashok Pusate, Sujeet Narain

Journal of Clinical Cardiology · 06.04.2026 · 7 (1) · 45

DOI: 10.33696/cardiology.7.088 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Cardiology, online erschienen am 06.04.2026. Verfasst von Chirag Jagdish Parikh und 3 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction and Objective: Semi-compliant (SC) balloons are essential in PCI for lesion preparation before stent deployment. The Optima SC PTCA balloon catheter, a next-generation device, was evaluated in this post-marketing, multicenter study to assess its real-world performance and safety.

Methods

This was a retrospective, observational study conducted across four interventional cardiology centers in India. A total of 183 adult patients with coronary artery disease who underwent PCI with Optima SC balloon pre-dilatation were included. Procedural and device success, adverse events, and operator-assessed device performance were evaluated. Patients were followed up to 3 months, as the time frame was adequate to establish procedural safety and performance of this PTCA catheter.

Results

Device and procedural success were achieved in 179 out of 183 patients (97.8%); failure in 2.2% was reported in complex lesions. No major adverse cardiac events (MACE), serious adverse events (SAE), or device-related complications were reported during hospital stay, though two clinical events (angina and target lesion failure) were reported in two patients during follow-up. Operator assessment rated performance satisfactory or better in >90% of cases across all parameters.

Conclusion

The Optima SC semi-compliant PTCA balloon catheter demonstrated a high procedural success rate and an excellent short-term safety profile in a real-world clinical setting. These findings support its use as a reliable and effective tool for coronary lesion pre-dilatation during PCI.

Zitieren

APA

Parikh, C. J., Sarda, A., Pusate, A. A., & Narain, S. (2026). Clinical Safety and Procedural Performance of the Optima SC Semi-compliant Percutaneous Transluminal Coronary Angioplasty Balloon Catheter in Coronary Intervention: A Multicenter Post-Market Study. Journal of Clinical Cardiology, 7(1), 45. https://doi.org/10.33696/cardiology.7.088

Vancouver

Parikh CJ, Sarda A, Pusate AA, Narain S. Clinical Safety and Procedural Performance of the Optima SC Semi-compliant Percutaneous Transluminal Coronary Angioplasty Balloon Catheter in Coronary Intervention: A Multicenter Post-Market Study. Journal of Clinical Cardiology. 2026;7(1):45. doi:10.33696/cardiology.7.088

BibTeX
@article{Parikh2026,
  author = {Parikh, Chirag Jagdish and Sarda, Anuj and Pusate, Anup Ashok and Narain, Sujeet},
  title = {Clinical Safety and Procedural Performance of the Optima SC Semi-compliant Percutaneous Transluminal Coronary Angioplasty Balloon Catheter in Coronary Intervention: A Multicenter Post-Market Study},
  journal = {Journal of Clinical Cardiology},
  year = {2026},
  volume = {7},
  number = {1},
  pages = {45},
  doi = {10.33696/cardiology.7.088}
}
Kostenlos starten →